#Tirzepatide #PeptideAPI #Pharma #API #CDMO #PharmaPhilippines #PharmaSourcing #PharmaceuticalManufacturing
@nikolospharma.bsky.social
@drtimos.bsky.socialSignal or noise? > One CRISPR treatment cut “bad” cholesterol in half for a
full year - ScienceDaily >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #competitivemarketing #healthcare #biotech #pharma
@tradersaan.bsky.socialHere's why I am long $PFE and NOT $LLY. 👀
$PFE $LLY #Pharma #Trading #Stocks #Investing
@abangelabs.bsky.socialSweden’s TLV estimates Kisunla at SEK 1.55m–4.54m per QALY, showing how durability assumptions drive value. https://www.mattheneus.com/editorial/tlv-kisunla-donanemab-cost-effectiveness-durability-scenarios-2026-09-22 #HTA #HealthEconomics #Pharma
@drtimos.bsky.social🚀 #DigitalHealth | #AI | #IoE 🌐
At #LucidQuest, we turn bold ideas into patient-centric, AI-powered solutions for #Pharma, #Biotech & #HealthTech.
Let’s shape the future of care together.
📩 [email protected] or
@abangelabs.bsky.socialPoland's HTA agency flags a comparator gap in Tevimbra's nasopharyngeal cancer submission. https://www.mattheneus.com/editorial/aotmit-tevimbra-nasopharyngeal-carcinoma-comparator-gap-assessment-2026-09-25 #HTA #Pharma #RegulatoryAffairs
@remotejobs2504.bsky.social💰 $30–$60/HR | MEDICAL WRITER (PHARMACEUTICAL) 📝💊
🌍 Remote
Medical writer with regulatory experience?
Use your clinical documentation skills to help train next-generation AI.
📝 Clinical Study Reports • ICH E3 • eCTD • Scientific Accuracy
@drtimos.bsky.socialSignal or noise? > Gene-Editing Detection Kits Market To 2035: Clinical Trials
Drive Growth - News and Statistics - IndexBox >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #competitivemarketing #healthcare #biotech
@midgardfinance.com
@abangelabs.bsky.socialRare-disease trials need a defensible statistical file before enrolment starts. #HTA #RegulatoryAffairs #Pharma https://www.mattheneus.com/editorial/fda-rise-rare-disease-trial-statistical-design-file-2026-09-29
@drtimos.bsky.socialSignal or noise? > Is uniQure (QURE) Undervalued Or Is Its Gene Therapy Promise
Already Priced In? - simplywall.st >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #healthcare #pharmaceutical #biotech
@marketingnewsdaily.bsky.socialGrocery execs largely unfazed by GLP-1 sales impact. CPGs adapting
Get faster indexing for your links and pages. https://www.UltimateIndexing.com
@abangelabs.bsky.socialHow often does living evidence stay living? Forty-one percent of syntheses issued an update within two years. #HTA #EvidenceSynthesis #Pharma https://www.mattheneus.com/editorial/living-evidence-synthesis-update-status-protocol-2026-09-25
@abangelabs.bsky.socialTenecteplase may improve outcomes and lower costs versus alteplase after acute ischaemic stroke in Canada. #HTA #HealthEconomics #Pharma https://www.mattheneus.com/editorial/pubmed-tenecteplase-alteplase-act-trial-canada-cost-effectiveness-2026-09-24
@abangelabs.bsky.socialWHO’s first target product profiles for novel male contraceptives set clear efficacy and development thresholds. #HTA #RegulatoryAffairs #Pharma https://www.mattheneus.com/editorial/who-novel-male-contraceptive-target-product-profiles-efficacy-thresholds-2026-09-22
@drtimos.bsky.socialSignal or noise? > Gene therapy & health equity in Sickle Cell
Awareness Month - FOX 5 Atlanta >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #competitivemarketing #biotech #pharma #healthcare
@drtimos.bsky.socialSignal or noise? > Retina Society 2026: Exudate control similar in Coats
disease and Coats-like disease in inherited retinal diseases -
Ophthalmology Times >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #healthcare #pharma #competitivemarketing
@drtimos.bsky.socialSignal or noise? > Indivior ends PAM drug collab with Addex ahead of Supernus
merger >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #healthcare #biotech #pharma #pharmaceutical
@drtimos.bsky.socialSignal or noise? > Ocugen's OCU410 gene therapy slows geographic atrophy lesion
growth by up to 32% in Phase 2 - Dealroom >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #biotech #competitivemarketing #pharmaceutical #pharma